EN DE

Zhejiang XinNong Chemical Co (002942) Fair Value & Analysis

Basic Materials · CN · Market cap 2.5B CNY

ZX Zhejiang XinNong Chemical Co 002942 · SHE
Price¥15.76
Fair Value¥10.41
Upside-34.0%
Quality70/100
Watch Zhejiang XinNong Chemical Co for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 8.7% net margin
Low debt · generates free cash flow
2.48% dividend yield
Mixed vs. peers (8/14)
Moderate moat 47/100
Evidence: High Range ¥7.80 – ¥13.01 Share as image

Fair value as of: Jul 22, 2026

From 26 valuation models · updated 20 days ago

Fair value updated Jul 22, 2026, revised from ¥10.80 to ¥10.41 (−3.6%) since Jun 25, 2026. Share price +8.9% over the past month.

A solid business, but screening 34% overvalued on our models.

What matters now

  • A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (¥13.01). The favourable scenario is already priced in.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥25.83 ¥9.47 Fair Value ¥10.41 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥9.47 – ¥25.83 · fair‑value band ¥7.80 – ¥13.01 · the ¥15.76 price screens above the ¥10.41 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Zhejiang XinNong Chemical Co (002942) currently trades at ¥15.76, while our model-based Fair Value estimate is ¥10.41, implying the stock looks roughly 34.0% overvalued today. The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Zhejiang XinNong Chemical Co generated revenue of 1.1B CNY at a net margin of 8.7%. Revenue grew 13.1% year over year. It earns a return on equity of 8.0%. The balance sheet holds a net cash position of 108M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥7.80 (bear case) to ¥13.01 (bull case); at ¥15.76, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 41% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -34%, 002942 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ¥7.46 ¥10.32 ¥14.33 80
Residual Income ¥6.43 ¥6.84 ¥7.48 76
Rev-Margin DCF ¥8.00 ¥12.18 ¥17.09 74
All 26 models by family
DCF Models
FCF DCF ¥7.40 ¥10.71 ¥15.68 38
Owner Earnings ¥8.96 ¥13.15 ¥19.45 31
5Y Revenue Exit ¥8.00 ¥12.21 ¥17.67 39
5Y EBITDA Exit ¥8.39 ¥12.95 ¥18.35 41
5Y P/E Exit ¥8.13 ¥12.46 ¥17.08 38
10Y Revenue Exit ¥7.50 ¥11.27 ¥16.47 36
10Y EBITDA Exit ¥7.96 ¥11.78 ¥16.99 37
10Y P/E Exit ¥7.80 ¥11.44 ¥16.02 35
Earnings-Based
Graham-Dodd ¥4.16 ¥14.13 ¥18.94 54
Lynch FV ¥3.24 ¥4.62 ¥6.01 50
PEG = 1.0 ¥3.24 ¥4.62 ¥6.01 46
EPV ¥7.91 ¥8.92 ¥9.78 59
Dividend Discount
Gordon GGM ¥2.63 ¥5.25 ¥7.95 70
DDM Multi-Stage ¥2.63 ¥4.46 ¥5.54 61
Multiples
P/E Multiple ¥7.80 ¥10.41 ¥13.01 63
P/S Multiple ¥7.80 ¥10.41 ¥13.01 58
P/B Multiple ¥7.80 ¥10.41 ¥13.01 55
EV/EBIT ¥9.72 ¥12.44 ¥15.16 53
EV/EBITDA ¥9.81 ¥12.56 ¥15.31 54
EV/Revenue ¥8.63 ¥11.66 ¥14.69 43
Asset-Based
NCAV (Graham) ¥3.92 ¥5.25 ¥7.84 50
Growth DCF
Growth DCF ¥7.46 ¥10.32 ¥14.33 80
Rev-Margin DCF ¥8.00 ¥12.18 ¥17.09 74
Economic Profit
Residual Income ¥6.43 ¥6.84 ¥7.48 76
ROIC Compounder ¥7.94 ¥9.56 ¥11.65 72
Growth Earnings
Growth-Adj P/E ¥6.84 ¥9.77 ¥12.70 68

Widest divergence: DCF Models (¥11.78) versus Dividend Discount (¥4.46). Highest evidence: Growth DCF (80).

Notify me when 002942 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 1.1B CNY
Revenue growth (YoY) +13.1%
Net margin 8.7%
Return on equity 8.0%
Free cash flow 82.5M CNY FY2025
P/E ratio 25.0
More key figures
Operating margin 15.5%
EPS (TTM) ¥0.6500
Dividend yield 2.5%
EPS growth (YoY) +11.1%
Net cash 108M CNY FY2024

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 70/100

Of which business quality 68 · Market factors (momentum, volatility) 32

Profitability 41
Margins and returns on capital today
Quality Growth 83
Are margins and returns improving?
Cashflow 48
Earnings quality: real cash, not paper profit
Fin. Strength 90
Balance sheet, leverage, solvency risk
Investment 94
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 12
Distance to the 52-week high (market factor)
Net Issuance 66
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Zhejiang XinNong Chemical Co.,Ltd. researches, develops, produces, and sells chemical pesticide technical, preparations and fine chemical intermediates in China. It operates through two segments: Technical Drugs and Intermediates, and Preparations.

Full company description

Zhejiang XinNong Chemical Co.,Ltd. researches, develops, produces, and sells chemical pesticide technical, preparations and fine chemical intermediates in China. It operates through two segments: Technical Drugs and Intermediates, and Preparations. The Technical Drugs and Intermediates segment produces triazophos technical, chlorpyrifos technical, zinc thiazole technical, pyraclostrobin technical, as well as intermediates such as ethyl chloride, N-(1-ethylpropyl)-3,4-dimethylaniline, phenylhydrazine and its salts, and 1,3-cyclohexanedione, which are primarily used in the synthesis of pesticides and pharmaceuticals. The Preparations segment offers zinc thiazole series preparations for bacterial diseases, pyraclostrobin series preparations for fungal diseases, chlorpyrifos series preparations for pest control, and triazophos series preparations for lepidopteran pests and mites. It also provides microbial agents and fertilizers. The company also exports its products to Southeast Asia, Europe, the United States, Australia, and Africa. Zhejiang XinNong Chemical Co.,Ltd. was founded in 1981 and is based in Hangzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Zhejiang XinNong Chemical Co reported revenue of ¥1.1B in FY2025 versus ¥1.2B in FY2021, a compound −1.2%/yr. Reported net income was ¥95.4M in FY2025, compounding −8.8%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
1.1B CNY
Latest YoY
+15.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.9%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.5%
Avg. growth/yr (13Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.4%
Revenue −1.2%/yr
FY21 ¥1.2B
FY22 ¥1.2B
FY23 ¥821M
FY24 ¥962M
FY25 ¥1.1B
Net income −8.8%/yr
FY21 ¥138M
FY22 ¥101M
FY23 −¥25.4M
FY24 ¥57.7M
FY25 ¥95.4M
Character of growth · EPS growth decomposed (2013-2024) −2.4 % p.a.
Revenue per share +5.2 pp

of which total revenue +8.4 pp · buybacks/dilution −3.2 pp

EBIT margin −0.4 pp
Tax rate +1.0 pp
Residual (interest, one-offs) −8.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

002942 screens 34% overvalued. Compare with Corteva, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Zhejiang XinNong Chemical Co Fair Value". https://www.fairvalue-calculator.com/stock/002942

Peer Group

Agricultural Inputs · 179 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 70 · Top 25%
Fair Value upside −34% · Below median
Return on equity (TTM) 8% · Above median
Return on assets 4% · Above median
Net margin (TTM) 9% · Above median
Operating margin (TTM) 16% · Top 25%
Revenue growth 13% · Above median
Dividend yield (TTM) 2.5% · Above median

Valuation Multiples vs Agricultural Inputs median · lower = cheaper

P/E (TTM) 25.0× · Pricier than median
P/B 2.07× · Pricier than median
P/S (TTM) 2.21× · Pricier than 75% of peers
P/FCF 4.6× · Pricier than median
EV/EBITDA 13.9× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 21
FUTURE 66 · sector 37
PAST 32 · sector 24
HEALTH 100 · sector 97
DIVIDEND 50 · sector 33

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $86.07 $27.81 -68%
Nutrien Ltd NTR C$94.23 C$81.69 -13%
Qinghai Salt Lake Industry Co 000792 ¥24.93 ¥21.26 -15%
CF Industries Holdings CF $119.19 $161.00 +35%
SABIC Agri-Nutrients Company 2020 122.90 SAR 127.31 SAR +4%
Yara International ASA YAR kr 451.30 kr 67.25 -85%
Yunnan Yuntianhua Co 600096 ¥30.17 ¥42.12 +40%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥42.59 ¥38.01 -11%
Coromandel International Limited COROMANDEL ₹2,034 ₹1,129 -44%
UPL Limited UPL ₹594.75 ₹387.06 -35%

Compare Zhejiang XinNong Chemical Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Zhejiang XinNong Chemical Co (002942) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥10.41 versus a price of ¥15.76, about −34% (overvalued).
What is the fair value of 002942?
Our model-based fair value for Zhejiang XinNong Chemical Co is ¥10.41 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥15.76.
What is the quality score of 002942?
Zhejiang XinNong Chemical Co has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Zhejiang XinNong Chemical Co (002942)?
Zhejiang XinNong Chemical Co reported trailing-twelve-month revenue of about 1.1B CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002942?
The net profit margin of Zhejiang XinNong Chemical Co is about 8.7%, meaning it keeps roughly 8.7% of revenue as net income. Based on the latest reported figures.
Does Zhejiang XinNong Chemical Co pay a dividend?
Zhejiang XinNong Chemical Co currently shows a dividend yield of about 2.48% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Zhejiang XinNong Chemical Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.